It was the first in a series of drugs that are, for the first time, effective against obesity and can help lessen the moral ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session on India Today Conclave 2025, said that many celebrities may not want to admit to taking Ozempic ...

A LOVED-UP mum’s bid to shine in her wedding dress went wrong after using a pharmacy-bought ‘fat jab’. Stephanie Hill decided to purchase a weight-loss injectable from an online ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side-effects of Ozempic. He said that the weight-loss drug has been through a thorough evaluation process.

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to ...

Arkansas Blue Cross and Blue Shield recently filed a loss totaling $226 million with the Arkansas Insurance Department for ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

GLP-1 medications have become a popular weight loss method, but what do Americans really think about them? To find out, we surveyed U.S. adults on their experiences.

Physicians need to meet patients ‘where they are’ to develop a comprehensive plan to keep weight off and live a healthy ...